Quick Answer: Thyroid hormone directly regulates the renewal of skin, hair, and nail cells, moisture balance, and sebaceous gland activity. In hypothyroidism, the skin appears dry, pale, and oedematous; hair becomes dry and sheds; nails turn brittle. In hyperthyroidism, the skin is moist, thin, and flushed; hair thins with diffuse shedding; some patients develop pretibial myxoedema. In both presentations, treating the underlying thyroid condition corrects the majority of cutaneous findings. Patients with uncontrolled thyroid dysfunction face a significant risk of complications from aesthetic procedures such as laser, filler, or chemical peeling. At Virtuana Clinic Izmit, we refer thyroid patients for endocrinology assessment before any aesthetic intervention.

Why Is Thyroid Hormone So Central to Skin Biology?

Thyroid hormones (T3 and T4) regulate the metabolic activity of virtually every cell in the body. The skin stands out as a tissue that reflects the effects of these hormones in a particularly pronounced way; the rate of epidermal renewal, dermal collagen synthesis, sebaceous gland secretory capacity, and the entire hair follicle cycle are all sensitive to thyroid hormone levels.

T3 receptors are densely expressed in the epithelium of human hair follicles, in the nuclei of epidermal keratinocytes, and in dermal fibroblasts. This anatomical fact explains why the cutaneous manifestations of thyroid disease both develop rapidly and resolve promptly with systemic treatment.

Hypothyroidism vs. Hyperthyroidism: Comparative Table of Cutaneous Findings

Skin / Hair / Nail Finding Hypothyroidism Hyperthyroidism / Graves'
Skin texture Coarse, dry, thick, rough Thin, smooth, velvety
Skin moisture Marked dryness, pruritus Excessive moisture, sweating
Skin colour Pale, yellowish (beta-carotene accumulation) Flushed, pink, with vitiligo association
Oedema Myxoedema (non-pitting, GAG accumulation) Pretibial myxoedema (Graves'-specific)
Hair Dry, brittle, diffuse shedding Fine, oily, diffuse shedding
Eyebrows and lashes Lateral eyebrow thinning (Hertoghe's sign) Usually normal; exophthalmos
Nails Brittle, slow-growing, ridged Plummer's nail (onycholysis)
Sweating Reduced, cold skin Increased, warm skin

The Skin in Hypothyroidism: Myxoedema and Xerosis

In hypothyroidism, thyroid hormone deficiency triggers the accumulation of glycosaminoglycans (GAGs) in the subcutaneous tissue. The resulting myxoedema manifests as non-pitting oedema (pressure does not leave an indentation) of the face and extremities. This presentation — facial puffiness, periorbital oedema, and a thickened voice — is characteristic of hypothyroidism.

However, the most frequently encountered cutaneous finding in hypothyroidism is xerosis (severe dryness), which results from a slowed rate of epidermal renewal, reduced sebaceous gland secretion, and increased transepidermal water loss. Clinically significant xerosis is detected in 74% of patients with untreated hypothyroidism. These patients may develop pruritus, ichthyosis vulgaris-like appearances, and eczematous dermatitis.

Slowed beta-carotene metabolism can produce a yellowish skin tone; this should not be confused with true jaundice (scleral colour remains normal).

Hair Loss in Hypothyroidism: Mechanism and Clinical Presentation

Thyroid hormone prolongs the anagen (growth) phase of the hair follicle and stimulates growth factors that maintain follicle size. In T3 deficiency, the anagen phase shortens, follicles enter the telogen (resting) phase prematurely, and diffuse telogen effluvium develops.

The characteristic features of hypothyroid-related hair loss are:

An important caveat: even when thyroid function is within the normal range, TSH values at the upper end of the reference interval (2.5–4.5 mIU/L) may predispose some patients to subclinical hair shedding. This grey zone requires a collaborative assessment between endocrinology and dermatology.

Cutaneous Findings in Hyperthyroidism: Graves' Disease and Pretibial Myxoedema

In Graves' disease (the most common cause of hyperthyroidism, autoimmune in origin), cutaneous findings reflect both the excess of thyroid hormone and the disease-specific autoimmune processes. Hyperthyroid skin is thin, moist, and warm, mirroring increased peripheral blood flow. Palmar erythema, telangiectasias, and pruritus are frequently observed.

Pretibial myxoedema (dermopathy) is a specific finding seen in approximately 1–4% of patients with Graves' disease. GAG accumulation beneath the skin on the anterior aspect of the tibia produces erythematous, nodular, or plaque-type lesions with an orange-peel appearance (peau d'orange). This lesion correlates with TSI (thyroid-stimulating immunoglobulin) levels and typically completes the Graves' triad together with exophthalmos and acropachy.

Plummer's nail (onycholysis): Characterised by separation of the nail plate from the nail bed, progressing from distal to proximal; a hallmark of hyperthyroidism most commonly affecting the ring finger, which resolves as hyperthyroidism is brought under control.

Autoimmune Thyroid Disease and Associated Dermatological Conditions

Hashimoto's thyroiditis and Graves' disease, as part of the polyglandular autoimmunity spectrum, may co-occur with various dermatological autoimmune conditions. Associations clinicians should be aware of:

Dermatological Condition Thyroid Co-occurrence Rate Clinical Note
Vitiligo 14–26% Thyroid screening is recommended in every vitiligo patient
Alopecia areata 8–28% Thyroid antibodies are frequently elevated
Chronic urticaria 14–30% Associated with anti-TPO positivity
Psoriasis 5–12% Shared autoimmune background

Treatment of Hair Loss in Thyroid Patients

The primary treatment of thyroid-related hair loss is correction of the underlying hormonal disorder. In hypothyroidism, appropriately dosed levothyroxine replacement therapy; in hyperthyroidism, antithyroid drugs, radioactive iodine, or surgery bring thyroid dysfunction under control. Once hormone levels are normalised, cessation of hair shedding and onset of regrowth typically occur within an average of 3–6 months.

An important practical point: following the initiation of hormone replacement, a transient increase in shedding may occur during the first 1–3 months as all body hair simultaneously renews. This "shedding phase" does not indicate treatment failure; on the contrary, it is evidence that the follicular cycle has restarted.

For persistent hair loss following hormonal control, serum ferritin (target ≥70 ng/mL), zinc, vitamin D3, and B12 levels should be assessed; supportive treatments such as topical minoxidil or PRP hair mesotherapy should be planned if necessary.

Aesthetic Procedure Safety in Thyroid Patients

Uncontrolled thyroid dysfunction significantly increases the risk of complications from aesthetic procedures. Our protocol at Virtuana Clinic is clear:

Tailored Skincare Protocol for Thyroid Patients

For hypothyroid skin, the primary objective is to support barrier function and reduce transepidermal water loss (TEWL):

For hyperthyroid skin, management of oily and moist skin takes centre stage: lightweight gel-based cleansers, oil-free moisturisers, and serums containing niacinamide and BHA (salicylic acid) are ideal choices.

Thyroid and the Skin: Which Signs Should Prompt a Medical Consultation?

When the following signs appear in combination, thyroid function testing is recommended:

Our Approach to Thyroid Patients at Virtuana Clinic

At Virtuana Clinic Izmit, we recommend endocrinology assessment for all patients presenting with cutaneous findings that may represent the skin manifestation of a systemic disease. For patients with well-controlled thyroid function, we prepare personalised care protocols and safe aesthetic treatment plans tailored to skin type and hormonal status.

This article is for informational purposes only. Please consult a qualified physician for treatment decisions.